Aurinia Pharmaceuticals Inc. (AUPH) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 32.56M | 44.57M | 44.45M | 44.24M | 1.3M | 30.11M | 17.03M | 15.84M | -18.6M | 14.31M | -13.28M | -2.83M | -31.67M | 10.45M | -15.36M | -27.87M | -46.75M | -25.92M | -40.25M | -37.98M |
| Operating CF Margin % | 41.9% | 57.8% | 60.5% | 63.19% | 2.08% | 50.3% | 25.13% | 27.7% | -36.97% | 31.74% | -24.35% | -6.81% | -92.04% | 36.75% | -27.54% | -98.86% | -216.17% | -110.76% | -274.43% | -573.7% |
| Operating CF Growth % | 2404.62% | 48.01% | 161.02% | 179.25% | 106.99% | 110.41% | 228.26% | 660.62% | 41.28% | 36.96% | 13.57% | 89.86% | 32.25% | 140.31% | 61.83% | 26.61% | 12.69% | -575.02% | -41.65% | -68.09% |
| Net Income | 34.35M | 210.79M | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M | 722K | -10.75M | -26.88M | -13.45M | -11.49M | -26.21M | -26.05M | -8.99M | -35.52M | -37.63M | -33.32M | -50.26M | -47.01M |
| Depreciation & Amortization | 2.5M | 4.86M | 4.87M | 4.86M | 4.86M | 4.86M | 4.89M | 4.84M | 4.85M | 4.95M | 5.26M | 719K | 717K | 219K | 809K | 840K | 838K | 688K | 766K | 576K |
| Stock-Based Compensation | -866K | 0 | 5.92M | 5.44M | -3.41M | 8.95M | 8.33M | 8.59M | 5.74M | 11.77M | 11.81M | 12.27M | 9.47M | 6.9M | 8.32M | 10.05M | 7.02M | 8.58M | 7.09M | 7.64M |
| Deferred Taxes | 9.28M | -176.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 165K | -1.23M | -3.95M | 6.7M | 1.48M | -7.6M | 867K | -3.44M | -7.67M | 5.04M | 7.57M | -6.44M | -2.39M | 283K | 540K | 997K | 1.51M | -102K | 13.91M | 7.73M |
| Working Capital Changes | -12.87M | 6.71M | 6.06M | 5.73M | -24.97M | 22.48M | -11.41M | 5.14M | -10.76M | 19.43M | -24.47M | 2.12M | -13.25M | 29.09M | -16.04M | -4.25M | -18.49M | -1.76M | -11.76M | -6.91M |
| Change in Receivables | -7.72M | -10.83M | 9.36M | 259K | -3.81M | -61K | -10.96M | 3.39M | -4.82M | 13.86M | -18.45M | -457K | -5.56M | 28.28M | -23.6M | 2.23M | -4.99M | -5.6M | -5.4M | -3.23M |
| Change in Inventory | -720K | -825.12K | 1.71M | -308K | -6.97M | -514K | 139K | 908K | -56K | -6.88M | -581K | -1.41M | -6.99M | -614K | -505K | -1.01M | -6.94M | -278K | -1.92M | -1.44M |
| Change in Payables | -652K | 1.14M | 0 | -901K | -974K | -74K | -3.15M | 2.74M | 1.34M | 1.58M | 0 | 5.36M | -4.12M | 0 | 7.12M | 462K | -6.7M | 0 | 118K | 0 |
| Cash from Investing | -18.08M | -36.89M | -13.77M | -13.27M | 31.03M | 39.22M | -10.57M | -38.62M | 49.23M | -6.26M | -19.7M | -5.61M | 24.86M | -3.02M | -50.22M | 45.62M | -53.02M | -5.49M | -32.81M | 1.67M |
| Capital Expenditures | -39K | -72K | -65K | -98K | -17K | -281K | 140K | -128K | -12K | -299K | 105K | -177K | -347K | -134K | -37.68K | -39K | -79K | -35K | 96K | -228K |
| CapEx % of Revenue | 0.05% | 0.09% | 0.09% | 0.14% | 0.03% | 0.47% | 0.21% | 0.22% | 0.02% | 0.66% | 0.19% | 0.43% | 1.01% | 0.47% | 0.07% | 0.14% | 0.37% | 0.15% | 0.65% | 3.44% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.68K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 13.71M | -13.71M | 0 | 0 | 226K | -269K | 0 | 0 | 240K | -19.81M | -11.91M | -162K | -2.88M | -421K | 0 | 0 | 0 | -6.16M | 1.9M |
| Cash from Financing | -53.69M | -511.44K | -10.49M | -44.39M | -49.34M | -23.05M | -2.72M | -8.27M | -15.05M | -5.58M | -2.33M | 1.14M | 1.64M | 688K | -23.87K | 1.34M | 405K | 205.72M | 9.08M | 1.28M |
| Debt Issued (Net) | -3.65M | -3.37M | -3.45M | -3.43M | -2.77M | -3.03M | -2.96M | -3.22M | -2.78M | -6.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -35.45M | 3.1M | -9.04M | -42.56M | -46.92M | -21.8M | 0 | -6.13M | -12.3M | 0 | 0 | 0 | 0 | 0 | -23.87K | 0 | 0 | 196.74M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -36.16M | 1.3M | -9.04M | -42.56M | -46.92M | -21.8M | 0 | -6.13M | -12.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -14.58M | -240.16K | 1.99M | 1.6M | 355K | 1.79M | 236K | 1.08M | 28K | 966K | -2.33M | 1.14M | 1.64M | 688K | 0 | 1.34M | 405K | 8.98M | 9.08M | 1.28M |
| Net Change in Cash | -39.2M | 7.02M | 20.19M | -13.43M | -17M | 46.29M | 3.73M | -31.05M | 15.58M | 2.48M | -35.31M | -7.29M | -5.17M | 8.12M | -65.58M | 19.09M | -99.36M | 174.31M | -63.97M | -35.03M |
| Free Cash Flow | 32.52M | 44.5M | 44.38M | 44.14M | 1.28M | 30.06M | 16.94M | 15.71M | -18.61M | 14.25M | -13.17M | -3.05M | -32.18M | 10.32M | -15.4M | -27.91M | -46.83M | -25.96M | -40.41M | -38.21M |
| FCF Margin % | 41.85% | 57.71% | 60.41% | 63.05% | 2.05% | 50.21% | 25% | 27.48% | -37% | 31.61% | -24.16% | -7.36% | -93.52% | 36.28% | -27.61% | -99% | -216.53% | -110.91% | -275.51% | -577.14% |
| FCF Growth % | 2434.76% | 48.05% | 161.95% | 180.9% | 106.89% | 110.89% | 228.64% | 614.74% | 42.17% | 38.16% | 14.47% | 89.06% | 31.28% | 139.74% | 61.89% | 26.95% | 14.43% | -2727.23% | -23.59% | -68.13% |
| FCF per Share | 0.24 | 0.32 | 0.33 | 0.31 | 0.01 | 0.20 | 0.12 | 0.11 | -0.13 | 0.10 | -0.09 | -0.02 | -0.23 | 0.07 | -0.11 | -0.20 | -0.33 | -0.20 | -0.31 | -0.30 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.21x | 1.41x | 2.06x | 0.06x | 21.07x | 1.19x | 21.94x | 1.73x | -0.53x | 0.99x | 0.25x | 1.21x | -0.40x | 1.71x | 0.78x | 1.24x | 0.78x | 0.80x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.46M | 0 | 0 | 0 | 276K | 1K | 0 | 0 | 779K | 0 | 21K | 0 | 0 |
| Taxes Paid | 1.33M | -1.07M | 0 | 820K | 246K | 0 | 0 | 1.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |